David P. Curley
Beaumont Hospital(IE)
Publications by Year
Research Areas
Epigenetics and DNA Methylation, Histone Deacetylase Inhibitors Research, Protein Degradation and Inhibitors, CAR-T cell therapy research, Cutaneous Melanoma Detection and Management
Most-Cited Works
- → BrafV600E cooperates with Pten loss to induce metastatic melanoma(2009)1,166 cited
- → MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors(2004)699 cited
- → Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype(2005)451 cited
- → The Composition of Human Milk and Infant Faecal Microbiota Over the First Three Months of Life: A Pilot Study(2017)430 cited
- → β-Catenin Signaling Controls Metastasis in Braf-Activated Pten-Deficient Melanomas(2011)341 cited
- → PML/RARα and FLT3-ITD induce an APL-like disease in a mouse model(2002)331 cited
- → CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML)(2002)307 cited
- → PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative disease(2003)217 cited
- → Epigenetic Silencing of Novel Tumor Suppressors in Malignant Melanoma(2006)168 cited
- → Characterization of melanocyte‐specific inducible Cre recombinase transgenic mice(2006)162 cited